NRT-23

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNRT-23
Drug Alias NameNRT-23
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectantsCannabinoid modulators
TargetsUpdating
Therapy Area/IndicationsPolyradiculoneuropathy, Chronic Inflammatory Demyelinating
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNectid
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNectid
Active IndicationsN/A
Inactive IndicationsPolyradiculoneuropathy, Chronic Inflammatory Demyelinating

Other Information

ATC CodeN/A
Related LinksN/A